Skip to main content

Sarcoma Research Group

Collaborating effectively to deliver advances in sarcoma surgery and therapeutics.

Our research

Sarcoma cancers are rare and diverse affecting a wide age range of people. Surgery is the mainstay of treatment. Alongside adjuvant radiotherapy and chemotherapy depending on the sarcoma type.

The Newcastle Sarcoma Research Group conducts translational research and worldwide collaboration. The group were the first in the world to perform fluorescence guided surgery for sarcoma resection and are developing a preclinical pipeline to optimise the technology for this.

Clinical care is delivered in Newcastle by the North of England Bone and Soft Tissue Tumour Service which receives referrals from a wide region including Cumbria, Greater Manchester, Leeds, and the Borders in Scotland.


Our aims

Identification of sarcoma cell surface targets for diagnosis, therapeutics and surgical imaging

Change clinical practice by performing relevant translational projects

Effective collaboration across scientific disciplines

Training of future sarcoma clinician scientists

Our funding

Our vital research, receives funding from our generous providers:

Bone Cancer Research Trust, Sarcoma UK, Newcastle Healthcare Charity, JGWP Foundation Trust, Cancer Research UK, Children with Cancer UK.

Group members

Translational and Clinical Research Institute, Paul O'Gorman Building

Kenneth RankinDaniel FrankelCorey Chan, Marcus Brookes.

Positron Emission Tomography Centre

George Petrides.

Centre for Synthetic Biology and Bioeconomy

Daniel Frankel.

School of Natural and Environmental Sciences

James Knight, Toni Pringle, Katie Gristwood.

Population Health Sciences Institute

Richard McNally.

Biosciences Institute

John Lunec.

Your support today will give researchers the means to save lives.